Traditional Chinese Medicine Enhances Efficacy of Immune Checkpoint Inhibitors
Traditional Chinese medicine (TCM) can enhance the efficacy of immune checkpoint inhibitors (ICIs) and reduce their toxicity.
Phase III
Oncology / Immunotherapy
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
The integration of traditional Chinese medicine (TCM) with immune checkpoint inhibitors (ICIs) presents a significant opportunity to enhance treatment efficacy and reduce adverse effects. This could reshape competitive dynamics in oncology, particularly in addressing drug resistance and improving patient outcomes.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor research developments on TCM and ICI combinations, as well as clinical trials assessing their synergistic effects.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.